Clinical Trial Update: A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating AK117 in combination with azacitidine and venetoclax in acute myeloid leukemia. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AK117 (AK117)
• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: Akeso | Conditions: ACUTE MYELOID LEUKEMIA; AML | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING